Description
Fdg is currently under investigation for the treatment of colorectal cancer and has not been approved by regulatory agencies like the FDA. Its clinical efficacy in this setting remains to be determined through ongoing clinical trials.
Mechanism of Action
Fdg is an investigational drug and its exact mechanism of action in colorectal cancer has not been fully elucidated; it is believed to target specific pathways involved in tumor growth and proliferation.
Side Effects
Side effects of Fdg are not well-documented as it is an investigational drug and more data is needed to fully characterize its safety profile;
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT00576563
Not Applicable
Archived
Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer
Netherlands